GlassScriptPhysician profile
William J Belles
NPI 1346275286
$15,227.66
in general payments reported to CMS, 2019-2025
21 companies · $617 in 2025
The $617 reported for 2025 was more than what 79% of Plastic Surgery Within The Head & Neck providers received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2020: $384 · 2021: $2,145 · 2022: $4,104 · 2023: $5,762 · 2024: $1,939 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,800 · Food and Beverage: $2,620 · Travel and Lodging: $897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,800.00 |
| Food and Beverage | $2,620.12 |
| Travel and Lodging | $897.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $10,000.48 | 2019-2025 | Nucala, Trelegy Ellipta |
| Aerin Medical INC. | $1,925.30 | 2020-2025 | |
| Optinose US, INC. | $586.42 | 2019-2024 | |
| Genzyme Corporation | $467.96 | 2019-2025 | |
| Inspire Medical Systems, INC. | $413.05 | 2022-2025 | Inspire |
| Medtronic, INC. | $315.24 | 2022-2025 | Pteye Parathyroid Detection System, Stealthstation S8 Platform |
| Alk-Abello, INC | $259.12 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $233.72 | 2021-2025 | Airsupra, Fasenra |
| Stryker Corporation | $193.81 | 2019-2022 | |
| Intersect Ent, INC. | $186.18 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $175.40 | 2019-2025 | Dupixent |
| Smith+Nephew, INC. | $125.27 | 2022 | |
| Acclarent, INC | $122.91 | 2022 | |
| Integra Lifesciences Corporation | $57.72 | 2019-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Karl Storz Endoscopy-America | $45.13 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $24.38 | 2023 | Matrixcombo |
| Paratek Pharmaceuticals, INC. | $23.20 | 2025 | Xhance |
| Amgen INC. | $20.88 | 2025 | Tezspire |
| Phathom Pharmaceuticals, INC. | $20.57 | 2024 | Voquezna |
| Horizon Therapeutics Plc | $16.29 | 2021 | |
| Pfizer INC. | $14.63 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Belles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.